Global Prebiotics

Prebiotics Comprehensive Study by Type (Fructo-Oligosaccharides, Insulin, Pyrodextrins, Galacto-Oligosaccharides, Soya Oligosaccharides, Lactulose, Isomalto-Oligosaccharides, Others), Application (Functional Food & Beverages, Non-Dairy Beverages, Dietary Supplements, Cereals, Infant Formula, Animal Feed), Disease Type (Diabetes, Infections, Cardiovascular Diseases, Osteoporosis, IBD, Immunomodulation, Others), Demography (Pediatric, Adult, Geriatric), Distribution Channel (Hypermarkets/Supermarkets, Pharmacies and Drug Stores, Specialty Stores, Online Sales) Players and Region - Global Market Outlook to 2030

Prebiotics Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 10.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Prebiotics
The upsurging consumer concerns about the effectiveness of prebiotics and preventive healthcare is further propelling the prebiotics market growth globally. and Prebiotics are dietary ingredients used for enhancing all the beneficial components present in indigenous gut microbiota. Dietary fibers in prebiotics work as carbon sources for secondary and primary fermentation trails in the colon backing the digestive health in numerous ways. The prebiotic market is also experiencing substantial growth, owing to the growing awareness of low-calorie consumable products and their associated health benefits. The demand for prebiotics has also increased due to the increasing consumption of functional foods, which have positive effects on health apart from just providing basic nutrition.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR10.1%


The major market players in the market are rigorously focusing on technological developments and investments to set up R&D facilities across various regions. Also, the key players have undertaken several business expansion strategies including M&A and new product development to meet the growing demand from food as well as beverages Industries. Analyst at AMA Research estimates that United States Vendors will contribute the maximum growth to Global Prebiotics market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Nutrition (United States), Cargill, Incorporated (United States), Danone SA (France), DuPont Nutrition & Health (Denmark), Nestl S.A. (Switzerland), Yakult Pharmaceutical Industry Co., Ltd. (Japan), Fonterra Co-operative Group Limited (New Zealand), Ingredion Incorporated (United States), CPIngredients, LLC (United States), Jarrow Formulas, Inc. (United States), Kerry Group plc (Ireland) and Kirkman Group, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Beghin Meiji S.A. (France), BENEO-Orafti SA (Belgium), FrieslandCampina Domo (United States), Weetabix Limited (United Kingdom), FrieslandCampina Domo (United States), Weetabix Limited (United Kingdom), Nexira SAS (France), Roquette America, Inc. (United States) and Royal FrieslandCampina N.V. (The Netherlands).

Segmentation Overview
AMA Research has segmented the market of Global Prebiotics market by Type (Fructo-Oligosaccharides, Insulin, Pyrodextrins, Galacto-Oligosaccharides, Soya Oligosaccharides, Lactulose, Isomalto-Oligosaccharides and Others), Application (Functional Food & Beverages, Non-Dairy Beverages, Dietary Supplements, Cereals, Infant Formula and Animal Feed) and Region.



On the basis of geography, the market of Prebiotics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Europe region held largest market share in the year 2023. North America, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Disease Type, the sub-segment i.e. Diabetes will boost the Prebiotics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Demography, the sub-segment i.e. Pediatric will boost the Prebiotics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hypermarkets/Supermarkets will boost the Prebiotics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Importance of the Animal Feed Ingredients and Growing Government Funding for the Discovery and Development of New Food Products

Market Growth Drivers:
Rising Use of Prebiotics in Several Dairy Products and Increasing Preference for Healthy Energy Drinks Over Conventional Carbonates

Challenges:
Stringent Regulatory Framework Associated with Prebiotics

Restraints:
Imbalanced Consumption of Prebiotics May Have Some Adverse Effects

Opportunities:
Growing Demand for Essential Ingredients in the Diet and Health Consciousness among Consumers across the Globe and Rapidly Growing Dairy Industry in Emerging Economies, such as China and India

Market Leaders and their expansionary development strategies
In 2020, R's KOSO launched 'R's KOSO', a traditional Japanese vegan prebiotic drink that has been fermented for one year using mushrooms, seaweed, fruits and plants as raw materials. This drink provides balanced nutrition to strengthen gut health and boost immunity.
In 2020, Friesland Campina Ingredient, a global innovator of healthy and functional ingredients, has launched Biotis, which aims to improve all essential functions such as maternal health, sleep, immunity, and intestinal health necessary for a healthy and active life.


Key Target Audience
Product Manufactures, Prebiotics Distributors, Prebiotics Suppliers, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Fructo-Oligosaccharides
  • Insulin
  • Pyrodextrins
  • Galacto-Oligosaccharides
  • Soya Oligosaccharides
  • Lactulose
  • Isomalto-Oligosaccharides
  • Others
By Application
  • Functional Food & Beverages
  • Non-Dairy Beverages
  • Dietary Supplements
  • Cereals
  • Infant Formula
  • Animal Feed
By Disease Type
  • Diabetes
  • Infections
  • Cardiovascular Diseases
  • Osteoporosis
  • IBD
  • Immunomodulation
  • Others

By Demography
  • Pediatric
  • Adult
  • Geriatric

By Distribution Channel
  • Hypermarkets/Supermarkets
  • Pharmacies and Drug Stores
  • Specialty Stores
  • Online Sales

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Use of Prebiotics in Several Dairy Products
      • 3.2.2. Increasing Preference for Healthy Energy Drinks Over Conventional Carbonates
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Framework Associated with Prebiotics
    • 3.4. Market Trends
      • 3.4.1. Increasing Importance of the Animal Feed Ingredients
      • 3.4.2. Growing Government Funding for the Discovery and Development of New Food Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Prebiotics, by Type, Application, Disease Type, Demography, Distribution Channel and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Prebiotics (Value)
      • 5.2.1. Global Prebiotics by: Type (Value)
        • 5.2.1.1. Fructo-Oligosaccharides
        • 5.2.1.2. Insulin
        • 5.2.1.3. Pyrodextrins
        • 5.2.1.4. Galacto-Oligosaccharides
        • 5.2.1.5. Soya Oligosaccharides
        • 5.2.1.6. Lactulose
        • 5.2.1.7. Isomalto-Oligosaccharides
        • 5.2.1.8. Others
      • 5.2.2. Global Prebiotics by: Application (Value)
        • 5.2.2.1. Functional Food & Beverages
        • 5.2.2.2. Non-Dairy Beverages
        • 5.2.2.3. Dietary Supplements
        • 5.2.2.4. Cereals
        • 5.2.2.5. Infant Formula
        • 5.2.2.6. Animal Feed
      • 5.2.3. Global Prebiotics by: Disease Type (Value)
        • 5.2.3.1. Diabetes
        • 5.2.3.2. Infections
        • 5.2.3.3. Cardiovascular Diseases
        • 5.2.3.4. Osteoporosis
        • 5.2.3.5. IBD
        • 5.2.3.6. Immunomodulation
        • 5.2.3.7. Others
      • 5.2.4. Global Prebiotics by: Demography (Value)
        • 5.2.4.1. Pediatric
        • 5.2.4.2. Adult
        • 5.2.4.3. Geriatric
      • 5.2.5. Global Prebiotics by: Distribution Channel (Value)
        • 5.2.5.1. Hypermarkets/Supermarkets
        • 5.2.5.2. Pharmacies and Drug Stores
        • 5.2.5.3. Specialty Stores
        • 5.2.5.4. Online Sales
      • 5.2.6. Global Prebiotics Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Prebiotics (Volume)
      • 5.3.1. Global Prebiotics by: Type (Volume)
        • 5.3.1.1. Fructo-Oligosaccharides
        • 5.3.1.2. Insulin
        • 5.3.1.3. Pyrodextrins
        • 5.3.1.4. Galacto-Oligosaccharides
        • 5.3.1.5. Soya Oligosaccharides
        • 5.3.1.6. Lactulose
        • 5.3.1.7. Isomalto-Oligosaccharides
        • 5.3.1.8. Others
      • 5.3.2. Global Prebiotics by: Application (Volume)
        • 5.3.2.1. Functional Food & Beverages
        • 5.3.2.2. Non-Dairy Beverages
        • 5.3.2.3. Dietary Supplements
        • 5.3.2.4. Cereals
        • 5.3.2.5. Infant Formula
        • 5.3.2.6. Animal Feed
      • 5.3.3. Global Prebiotics by: Disease Type (Volume)
        • 5.3.3.1. Diabetes
        • 5.3.3.2. Infections
        • 5.3.3.3. Cardiovascular Diseases
        • 5.3.3.4. Osteoporosis
        • 5.3.3.5. IBD
        • 5.3.3.6. Immunomodulation
        • 5.3.3.7. Others
      • 5.3.4. Global Prebiotics by: Demography (Volume)
        • 5.3.4.1. Pediatric
        • 5.3.4.2. Adult
        • 5.3.4.3. Geriatric
      • 5.3.5. Global Prebiotics by: Distribution Channel (Volume)
        • 5.3.5.1. Hypermarkets/Supermarkets
        • 5.3.5.2. Pharmacies and Drug Stores
        • 5.3.5.3. Specialty Stores
        • 5.3.5.4. Online Sales
      • 5.3.6. Global Prebiotics Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Prebiotics (Price)
      • 5.4.1. Global Prebiotics by: Type (Price)
  • 6. Prebiotics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Nutrition (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cargill, Incorporated (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Danone SA (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DuPont Nutrition & Health (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nestl S.A. (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Yakult Pharmaceutical Industry Co., Ltd. (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fonterra Co-operative Group Limited (New Zealand)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ingredion Incorporated (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CPIngredients, LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Jarrow Formulas, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Kerry Group plc (Ireland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Kirkman Group, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Prebiotics Sale, by Type, Application, Disease Type, Demography, Distribution Channel and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Prebiotics (Value)
      • 7.2.1. Global Prebiotics by: Type (Value)
        • 7.2.1.1. Fructo-Oligosaccharides
        • 7.2.1.2. Insulin
        • 7.2.1.3. Pyrodextrins
        • 7.2.1.4. Galacto-Oligosaccharides
        • 7.2.1.5. Soya Oligosaccharides
        • 7.2.1.6. Lactulose
        • 7.2.1.7. Isomalto-Oligosaccharides
        • 7.2.1.8. Others
      • 7.2.2. Global Prebiotics by: Application (Value)
        • 7.2.2.1. Functional Food & Beverages
        • 7.2.2.2. Non-Dairy Beverages
        • 7.2.2.3. Dietary Supplements
        • 7.2.2.4. Cereals
        • 7.2.2.5. Infant Formula
        • 7.2.2.6. Animal Feed
      • 7.2.3. Global Prebiotics by: Disease Type (Value)
        • 7.2.3.1. Diabetes
        • 7.2.3.2. Infections
        • 7.2.3.3. Cardiovascular Diseases
        • 7.2.3.4. Osteoporosis
        • 7.2.3.5. IBD
        • 7.2.3.6. Immunomodulation
        • 7.2.3.7. Others
      • 7.2.4. Global Prebiotics by: Demography (Value)
        • 7.2.4.1. Pediatric
        • 7.2.4.2. Adult
        • 7.2.4.3. Geriatric
      • 7.2.5. Global Prebiotics by: Distribution Channel (Value)
        • 7.2.5.1. Hypermarkets/Supermarkets
        • 7.2.5.2. Pharmacies and Drug Stores
        • 7.2.5.3. Specialty Stores
        • 7.2.5.4. Online Sales
      • 7.2.6. Global Prebiotics Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Prebiotics (Volume)
      • 7.3.1. Global Prebiotics by: Type (Volume)
        • 7.3.1.1. Fructo-Oligosaccharides
        • 7.3.1.2. Insulin
        • 7.3.1.3. Pyrodextrins
        • 7.3.1.4. Galacto-Oligosaccharides
        • 7.3.1.5. Soya Oligosaccharides
        • 7.3.1.6. Lactulose
        • 7.3.1.7. Isomalto-Oligosaccharides
        • 7.3.1.8. Others
      • 7.3.2. Global Prebiotics by: Application (Volume)
        • 7.3.2.1. Functional Food & Beverages
        • 7.3.2.2. Non-Dairy Beverages
        • 7.3.2.3. Dietary Supplements
        • 7.3.2.4. Cereals
        • 7.3.2.5. Infant Formula
        • 7.3.2.6. Animal Feed
      • 7.3.3. Global Prebiotics by: Disease Type (Volume)
        • 7.3.3.1. Diabetes
        • 7.3.3.2. Infections
        • 7.3.3.3. Cardiovascular Diseases
        • 7.3.3.4. Osteoporosis
        • 7.3.3.5. IBD
        • 7.3.3.6. Immunomodulation
        • 7.3.3.7. Others
      • 7.3.4. Global Prebiotics by: Demography (Volume)
        • 7.3.4.1. Pediatric
        • 7.3.4.2. Adult
        • 7.3.4.3. Geriatric
      • 7.3.5. Global Prebiotics by: Distribution Channel (Volume)
        • 7.3.5.1. Hypermarkets/Supermarkets
        • 7.3.5.2. Pharmacies and Drug Stores
        • 7.3.5.3. Specialty Stores
        • 7.3.5.4. Online Sales
      • 7.3.6. Global Prebiotics Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Prebiotics (Price)
      • 7.4.1. Global Prebiotics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Prebiotics: by Type(USD Million)
  • Table 2. Prebiotics Fructo-Oligosaccharides , by Region USD Million (2018-2023)
  • Table 3. Prebiotics Insulin , by Region USD Million (2018-2023)
  • Table 4. Prebiotics Pyrodextrins , by Region USD Million (2018-2023)
  • Table 5. Prebiotics Galacto-Oligosaccharides , by Region USD Million (2018-2023)
  • Table 6. Prebiotics Soya Oligosaccharides , by Region USD Million (2018-2023)
  • Table 7. Prebiotics Lactulose , by Region USD Million (2018-2023)
  • Table 8. Prebiotics Isomalto-Oligosaccharides , by Region USD Million (2018-2023)
  • Table 9. Prebiotics Others , by Region USD Million (2018-2023)
  • Table 10. Prebiotics: by Application(USD Million)
  • Table 11. Prebiotics Functional Food & Beverages , by Region USD Million (2018-2023)
  • Table 12. Prebiotics Non-Dairy Beverages , by Region USD Million (2018-2023)
  • Table 13. Prebiotics Dietary Supplements , by Region USD Million (2018-2023)
  • Table 14. Prebiotics Cereals , by Region USD Million (2018-2023)
  • Table 15. Prebiotics Infant Formula , by Region USD Million (2018-2023)
  • Table 16. Prebiotics Animal Feed , by Region USD Million (2018-2023)
  • Table 17. Prebiotics: by Disease Type(USD Million)
  • Table 18. Prebiotics Diabetes , by Region USD Million (2018-2023)
  • Table 19. Prebiotics Infections , by Region USD Million (2018-2023)
  • Table 20. Prebiotics Cardiovascular Diseases , by Region USD Million (2018-2023)
  • Table 21. Prebiotics Osteoporosis , by Region USD Million (2018-2023)
  • Table 22. Prebiotics IBD , by Region USD Million (2018-2023)
  • Table 23. Prebiotics Immunomodulation , by Region USD Million (2018-2023)
  • Table 24. Prebiotics Others , by Region USD Million (2018-2023)
  • Table 25. Prebiotics: by Demography(USD Million)
  • Table 26. Prebiotics Pediatric , by Region USD Million (2018-2023)
  • Table 27. Prebiotics Adult , by Region USD Million (2018-2023)
  • Table 28. Prebiotics Geriatric , by Region USD Million (2018-2023)
  • Table 29. Prebiotics: by Distribution Channel(USD Million)
  • Table 30. Prebiotics Hypermarkets/Supermarkets , by Region USD Million (2018-2023)
  • Table 31. Prebiotics Pharmacies and Drug Stores , by Region USD Million (2018-2023)
  • Table 32. Prebiotics Specialty Stores , by Region USD Million (2018-2023)
  • Table 33. Prebiotics Online Sales , by Region USD Million (2018-2023)
  • Table 34. South America Prebiotics, by Country USD Million (2018-2023)
  • Table 35. South America Prebiotics, by Type USD Million (2018-2023)
  • Table 36. South America Prebiotics, by Application USD Million (2018-2023)
  • Table 37. South America Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 38. South America Prebiotics, by Demography USD Million (2018-2023)
  • Table 39. South America Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 40. Brazil Prebiotics, by Type USD Million (2018-2023)
  • Table 41. Brazil Prebiotics, by Application USD Million (2018-2023)
  • Table 42. Brazil Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 43. Brazil Prebiotics, by Demography USD Million (2018-2023)
  • Table 44. Brazil Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 45. Argentina Prebiotics, by Type USD Million (2018-2023)
  • Table 46. Argentina Prebiotics, by Application USD Million (2018-2023)
  • Table 47. Argentina Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 48. Argentina Prebiotics, by Demography USD Million (2018-2023)
  • Table 49. Argentina Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 50. Rest of South America Prebiotics, by Type USD Million (2018-2023)
  • Table 51. Rest of South America Prebiotics, by Application USD Million (2018-2023)
  • Table 52. Rest of South America Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 53. Rest of South America Prebiotics, by Demography USD Million (2018-2023)
  • Table 54. Rest of South America Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 55. Asia Pacific Prebiotics, by Country USD Million (2018-2023)
  • Table 56. Asia Pacific Prebiotics, by Type USD Million (2018-2023)
  • Table 57. Asia Pacific Prebiotics, by Application USD Million (2018-2023)
  • Table 58. Asia Pacific Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 59. Asia Pacific Prebiotics, by Demography USD Million (2018-2023)
  • Table 60. Asia Pacific Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 61. China Prebiotics, by Type USD Million (2018-2023)
  • Table 62. China Prebiotics, by Application USD Million (2018-2023)
  • Table 63. China Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 64. China Prebiotics, by Demography USD Million (2018-2023)
  • Table 65. China Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 66. Japan Prebiotics, by Type USD Million (2018-2023)
  • Table 67. Japan Prebiotics, by Application USD Million (2018-2023)
  • Table 68. Japan Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 69. Japan Prebiotics, by Demography USD Million (2018-2023)
  • Table 70. Japan Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 71. India Prebiotics, by Type USD Million (2018-2023)
  • Table 72. India Prebiotics, by Application USD Million (2018-2023)
  • Table 73. India Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 74. India Prebiotics, by Demography USD Million (2018-2023)
  • Table 75. India Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 76. South Korea Prebiotics, by Type USD Million (2018-2023)
  • Table 77. South Korea Prebiotics, by Application USD Million (2018-2023)
  • Table 78. South Korea Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 79. South Korea Prebiotics, by Demography USD Million (2018-2023)
  • Table 80. South Korea Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 81. Taiwan Prebiotics, by Type USD Million (2018-2023)
  • Table 82. Taiwan Prebiotics, by Application USD Million (2018-2023)
  • Table 83. Taiwan Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 84. Taiwan Prebiotics, by Demography USD Million (2018-2023)
  • Table 85. Taiwan Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 86. Australia Prebiotics, by Type USD Million (2018-2023)
  • Table 87. Australia Prebiotics, by Application USD Million (2018-2023)
  • Table 88. Australia Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 89. Australia Prebiotics, by Demography USD Million (2018-2023)
  • Table 90. Australia Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 91. Rest of Asia-Pacific Prebiotics, by Type USD Million (2018-2023)
  • Table 92. Rest of Asia-Pacific Prebiotics, by Application USD Million (2018-2023)
  • Table 93. Rest of Asia-Pacific Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 94. Rest of Asia-Pacific Prebiotics, by Demography USD Million (2018-2023)
  • Table 95. Rest of Asia-Pacific Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 96. Europe Prebiotics, by Country USD Million (2018-2023)
  • Table 97. Europe Prebiotics, by Type USD Million (2018-2023)
  • Table 98. Europe Prebiotics, by Application USD Million (2018-2023)
  • Table 99. Europe Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 100. Europe Prebiotics, by Demography USD Million (2018-2023)
  • Table 101. Europe Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 102. Germany Prebiotics, by Type USD Million (2018-2023)
  • Table 103. Germany Prebiotics, by Application USD Million (2018-2023)
  • Table 104. Germany Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 105. Germany Prebiotics, by Demography USD Million (2018-2023)
  • Table 106. Germany Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 107. France Prebiotics, by Type USD Million (2018-2023)
  • Table 108. France Prebiotics, by Application USD Million (2018-2023)
  • Table 109. France Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 110. France Prebiotics, by Demography USD Million (2018-2023)
  • Table 111. France Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 112. Italy Prebiotics, by Type USD Million (2018-2023)
  • Table 113. Italy Prebiotics, by Application USD Million (2018-2023)
  • Table 114. Italy Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 115. Italy Prebiotics, by Demography USD Million (2018-2023)
  • Table 116. Italy Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 117. United Kingdom Prebiotics, by Type USD Million (2018-2023)
  • Table 118. United Kingdom Prebiotics, by Application USD Million (2018-2023)
  • Table 119. United Kingdom Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 120. United Kingdom Prebiotics, by Demography USD Million (2018-2023)
  • Table 121. United Kingdom Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 122. Netherlands Prebiotics, by Type USD Million (2018-2023)
  • Table 123. Netherlands Prebiotics, by Application USD Million (2018-2023)
  • Table 124. Netherlands Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 125. Netherlands Prebiotics, by Demography USD Million (2018-2023)
  • Table 126. Netherlands Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 127. Rest of Europe Prebiotics, by Type USD Million (2018-2023)
  • Table 128. Rest of Europe Prebiotics, by Application USD Million (2018-2023)
  • Table 129. Rest of Europe Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 130. Rest of Europe Prebiotics, by Demography USD Million (2018-2023)
  • Table 131. Rest of Europe Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 132. MEA Prebiotics, by Country USD Million (2018-2023)
  • Table 133. MEA Prebiotics, by Type USD Million (2018-2023)
  • Table 134. MEA Prebiotics, by Application USD Million (2018-2023)
  • Table 135. MEA Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 136. MEA Prebiotics, by Demography USD Million (2018-2023)
  • Table 137. MEA Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 138. Middle East Prebiotics, by Type USD Million (2018-2023)
  • Table 139. Middle East Prebiotics, by Application USD Million (2018-2023)
  • Table 140. Middle East Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 141. Middle East Prebiotics, by Demography USD Million (2018-2023)
  • Table 142. Middle East Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 143. Africa Prebiotics, by Type USD Million (2018-2023)
  • Table 144. Africa Prebiotics, by Application USD Million (2018-2023)
  • Table 145. Africa Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 146. Africa Prebiotics, by Demography USD Million (2018-2023)
  • Table 147. Africa Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 148. North America Prebiotics, by Country USD Million (2018-2023)
  • Table 149. North America Prebiotics, by Type USD Million (2018-2023)
  • Table 150. North America Prebiotics, by Application USD Million (2018-2023)
  • Table 151. North America Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 152. North America Prebiotics, by Demography USD Million (2018-2023)
  • Table 153. North America Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 154. United States Prebiotics, by Type USD Million (2018-2023)
  • Table 155. United States Prebiotics, by Application USD Million (2018-2023)
  • Table 156. United States Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 157. United States Prebiotics, by Demography USD Million (2018-2023)
  • Table 158. United States Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 159. Canada Prebiotics, by Type USD Million (2018-2023)
  • Table 160. Canada Prebiotics, by Application USD Million (2018-2023)
  • Table 161. Canada Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 162. Canada Prebiotics, by Demography USD Million (2018-2023)
  • Table 163. Canada Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 164. Mexico Prebiotics, by Type USD Million (2018-2023)
  • Table 165. Mexico Prebiotics, by Application USD Million (2018-2023)
  • Table 166. Mexico Prebiotics, by Disease Type USD Million (2018-2023)
  • Table 167. Mexico Prebiotics, by Demography USD Million (2018-2023)
  • Table 168. Mexico Prebiotics, by Distribution Channel USD Million (2018-2023)
  • Table 169. Prebiotics Sales: by Type(Kilo Tons)
  • Table 170. Prebiotics Sales Fructo-Oligosaccharides , by Region Kilo Tons (2018-2023)
  • Table 171. Prebiotics Sales Insulin , by Region Kilo Tons (2018-2023)
  • Table 172. Prebiotics Sales Pyrodextrins , by Region Kilo Tons (2018-2023)
  • Table 173. Prebiotics Sales Galacto-Oligosaccharides , by Region Kilo Tons (2018-2023)
  • Table 174. Prebiotics Sales Soya Oligosaccharides , by Region Kilo Tons (2018-2023)
  • Table 175. Prebiotics Sales Lactulose , by Region Kilo Tons (2018-2023)
  • Table 176. Prebiotics Sales Isomalto-Oligosaccharides , by Region Kilo Tons (2018-2023)
  • Table 177. Prebiotics Sales Others , by Region Kilo Tons (2018-2023)
  • Table 178. Prebiotics Sales: by Application(Kilo Tons)
  • Table 179. Prebiotics Sales Functional Food & Beverages , by Region Kilo Tons (2018-2023)
  • Table 180. Prebiotics Sales Non-Dairy Beverages , by Region Kilo Tons (2018-2023)
  • Table 181. Prebiotics Sales Dietary Supplements , by Region Kilo Tons (2018-2023)
  • Table 182. Prebiotics Sales Cereals , by Region Kilo Tons (2018-2023)
  • Table 183. Prebiotics Sales Infant Formula , by Region Kilo Tons (2018-2023)
  • Table 184. Prebiotics Sales Animal Feed , by Region Kilo Tons (2018-2023)
  • Table 185. Prebiotics Sales: by Disease Type(Kilo Tons)
  • Table 186. Prebiotics Sales Diabetes , by Region Kilo Tons (2018-2023)
  • Table 187. Prebiotics Sales Infections , by Region Kilo Tons (2018-2023)
  • Table 188. Prebiotics Sales Cardiovascular Diseases , by Region Kilo Tons (2018-2023)
  • Table 189. Prebiotics Sales Osteoporosis , by Region Kilo Tons (2018-2023)
  • Table 190. Prebiotics Sales IBD , by Region Kilo Tons (2018-2023)
  • Table 191. Prebiotics Sales Immunomodulation , by Region Kilo Tons (2018-2023)
  • Table 192. Prebiotics Sales Others , by Region Kilo Tons (2018-2023)
  • Table 193. Prebiotics Sales: by Demography(Kilo Tons)
  • Table 194. Prebiotics Sales Pediatric , by Region Kilo Tons (2018-2023)
  • Table 195. Prebiotics Sales Adult , by Region Kilo Tons (2018-2023)
  • Table 196. Prebiotics Sales Geriatric , by Region Kilo Tons (2018-2023)
  • Table 197. Prebiotics Sales: by Distribution Channel(Kilo Tons)
  • Table 198. Prebiotics Sales Hypermarkets/Supermarkets , by Region Kilo Tons (2018-2023)
  • Table 199. Prebiotics Sales Pharmacies and Drug Stores , by Region Kilo Tons (2018-2023)
  • Table 200. Prebiotics Sales Specialty Stores , by Region Kilo Tons (2018-2023)
  • Table 201. Prebiotics Sales Online Sales , by Region Kilo Tons (2018-2023)
  • Table 202. South America Prebiotics Sales, by Country Kilo Tons (2018-2023)
  • Table 203. South America Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 204. South America Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 205. South America Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 206. South America Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 207. South America Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 208. Brazil Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 209. Brazil Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 210. Brazil Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 211. Brazil Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 212. Brazil Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 213. Argentina Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 214. Argentina Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 215. Argentina Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 216. Argentina Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 217. Argentina Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 218. Rest of South America Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 219. Rest of South America Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 220. Rest of South America Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 221. Rest of South America Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 222. Rest of South America Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 223. Asia Pacific Prebiotics Sales, by Country Kilo Tons (2018-2023)
  • Table 224. Asia Pacific Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 225. Asia Pacific Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 226. Asia Pacific Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 227. Asia Pacific Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 228. Asia Pacific Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 229. China Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 230. China Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 231. China Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 232. China Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 233. China Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 234. Japan Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 235. Japan Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 236. Japan Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 237. Japan Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 238. Japan Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 239. India Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 240. India Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 241. India Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 242. India Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 243. India Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 244. South Korea Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 245. South Korea Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 246. South Korea Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 247. South Korea Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 248. South Korea Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 249. Taiwan Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 250. Taiwan Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 251. Taiwan Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 252. Taiwan Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 253. Taiwan Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 254. Australia Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 255. Australia Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 256. Australia Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 257. Australia Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 258. Australia Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 259. Rest of Asia-Pacific Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 260. Rest of Asia-Pacific Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 261. Rest of Asia-Pacific Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 262. Rest of Asia-Pacific Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 263. Rest of Asia-Pacific Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 264. Europe Prebiotics Sales, by Country Kilo Tons (2018-2023)
  • Table 265. Europe Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 266. Europe Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 267. Europe Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 268. Europe Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 269. Europe Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 270. Germany Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 271. Germany Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 272. Germany Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 273. Germany Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 274. Germany Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 275. France Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 276. France Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 277. France Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 278. France Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 279. France Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 280. Italy Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 281. Italy Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 282. Italy Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 283. Italy Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 284. Italy Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 285. United Kingdom Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 286. United Kingdom Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 287. United Kingdom Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 288. United Kingdom Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 289. United Kingdom Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 290. Netherlands Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 291. Netherlands Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 292. Netherlands Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 293. Netherlands Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 294. Netherlands Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 295. Rest of Europe Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 296. Rest of Europe Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 297. Rest of Europe Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 298. Rest of Europe Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 299. Rest of Europe Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 300. MEA Prebiotics Sales, by Country Kilo Tons (2018-2023)
  • Table 301. MEA Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 302. MEA Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 303. MEA Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 304. MEA Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 305. MEA Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 306. Middle East Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 307. Middle East Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 308. Middle East Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 309. Middle East Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 310. Middle East Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 311. Africa Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 312. Africa Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 313. Africa Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 314. Africa Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 315. Africa Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 316. North America Prebiotics Sales, by Country Kilo Tons (2018-2023)
  • Table 317. North America Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 318. North America Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 319. North America Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 320. North America Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 321. North America Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 322. United States Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 323. United States Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 324. United States Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 325. United States Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 326. United States Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 327. Canada Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 328. Canada Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 329. Canada Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 330. Canada Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 331. Canada Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 332. Mexico Prebiotics Sales, by Type Kilo Tons (2018-2023)
  • Table 333. Mexico Prebiotics Sales, by Application Kilo Tons (2018-2023)
  • Table 334. Mexico Prebiotics Sales, by Disease Type Kilo Tons (2018-2023)
  • Table 335. Mexico Prebiotics Sales, by Demography Kilo Tons (2018-2023)
  • Table 336. Mexico Prebiotics Sales, by Distribution Channel Kilo Tons (2018-2023)
  • Table 337. Prebiotics: by Type(USD/Units)
  • Table 338. Company Basic Information, Sales Area and Its Competitors
  • Table 339. Company Basic Information, Sales Area and Its Competitors
  • Table 340. Company Basic Information, Sales Area and Its Competitors
  • Table 341. Company Basic Information, Sales Area and Its Competitors
  • Table 342. Company Basic Information, Sales Area and Its Competitors
  • Table 343. Company Basic Information, Sales Area and Its Competitors
  • Table 344. Company Basic Information, Sales Area and Its Competitors
  • Table 345. Company Basic Information, Sales Area and Its Competitors
  • Table 346. Company Basic Information, Sales Area and Its Competitors
  • Table 347. Company Basic Information, Sales Area and Its Competitors
  • Table 348. Company Basic Information, Sales Area and Its Competitors
  • Table 349. Company Basic Information, Sales Area and Its Competitors
  • Table 350. Prebiotics: by Type(USD Million)
  • Table 351. Prebiotics Fructo-Oligosaccharides , by Region USD Million (2025-2030)
  • Table 352. Prebiotics Insulin , by Region USD Million (2025-2030)
  • Table 353. Prebiotics Pyrodextrins , by Region USD Million (2025-2030)
  • Table 354. Prebiotics Galacto-Oligosaccharides , by Region USD Million (2025-2030)
  • Table 355. Prebiotics Soya Oligosaccharides , by Region USD Million (2025-2030)
  • Table 356. Prebiotics Lactulose , by Region USD Million (2025-2030)
  • Table 357. Prebiotics Isomalto-Oligosaccharides , by Region USD Million (2025-2030)
  • Table 358. Prebiotics Others , by Region USD Million (2025-2030)
  • Table 359. Prebiotics: by Application(USD Million)
  • Table 360. Prebiotics Functional Food & Beverages , by Region USD Million (2025-2030)
  • Table 361. Prebiotics Non-Dairy Beverages , by Region USD Million (2025-2030)
  • Table 362. Prebiotics Dietary Supplements , by Region USD Million (2025-2030)
  • Table 363. Prebiotics Cereals , by Region USD Million (2025-2030)
  • Table 364. Prebiotics Infant Formula , by Region USD Million (2025-2030)
  • Table 365. Prebiotics Animal Feed , by Region USD Million (2025-2030)
  • Table 366. Prebiotics: by Disease Type(USD Million)
  • Table 367. Prebiotics Diabetes , by Region USD Million (2025-2030)
  • Table 368. Prebiotics Infections , by Region USD Million (2025-2030)
  • Table 369. Prebiotics Cardiovascular Diseases , by Region USD Million (2025-2030)
  • Table 370. Prebiotics Osteoporosis , by Region USD Million (2025-2030)
  • Table 371. Prebiotics IBD , by Region USD Million (2025-2030)
  • Table 372. Prebiotics Immunomodulation , by Region USD Million (2025-2030)
  • Table 373. Prebiotics Others , by Region USD Million (2025-2030)
  • Table 374. Prebiotics: by Demography(USD Million)
  • Table 375. Prebiotics Pediatric , by Region USD Million (2025-2030)
  • Table 376. Prebiotics Adult , by Region USD Million (2025-2030)
  • Table 377. Prebiotics Geriatric , by Region USD Million (2025-2030)
  • Table 378. Prebiotics: by Distribution Channel(USD Million)
  • Table 379. Prebiotics Hypermarkets/Supermarkets , by Region USD Million (2025-2030)
  • Table 380. Prebiotics Pharmacies and Drug Stores , by Region USD Million (2025-2030)
  • Table 381. Prebiotics Specialty Stores , by Region USD Million (2025-2030)
  • Table 382. Prebiotics Online Sales , by Region USD Million (2025-2030)
  • Table 383. South America Prebiotics, by Country USD Million (2025-2030)
  • Table 384. South America Prebiotics, by Type USD Million (2025-2030)
  • Table 385. South America Prebiotics, by Application USD Million (2025-2030)
  • Table 386. South America Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 387. South America Prebiotics, by Demography USD Million (2025-2030)
  • Table 388. South America Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 389. Brazil Prebiotics, by Type USD Million (2025-2030)
  • Table 390. Brazil Prebiotics, by Application USD Million (2025-2030)
  • Table 391. Brazil Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 392. Brazil Prebiotics, by Demography USD Million (2025-2030)
  • Table 393. Brazil Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 394. Argentina Prebiotics, by Type USD Million (2025-2030)
  • Table 395. Argentina Prebiotics, by Application USD Million (2025-2030)
  • Table 396. Argentina Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 397. Argentina Prebiotics, by Demography USD Million (2025-2030)
  • Table 398. Argentina Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 399. Rest of South America Prebiotics, by Type USD Million (2025-2030)
  • Table 400. Rest of South America Prebiotics, by Application USD Million (2025-2030)
  • Table 401. Rest of South America Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 402. Rest of South America Prebiotics, by Demography USD Million (2025-2030)
  • Table 403. Rest of South America Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 404. Asia Pacific Prebiotics, by Country USD Million (2025-2030)
  • Table 405. Asia Pacific Prebiotics, by Type USD Million (2025-2030)
  • Table 406. Asia Pacific Prebiotics, by Application USD Million (2025-2030)
  • Table 407. Asia Pacific Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 408. Asia Pacific Prebiotics, by Demography USD Million (2025-2030)
  • Table 409. Asia Pacific Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 410. China Prebiotics, by Type USD Million (2025-2030)
  • Table 411. China Prebiotics, by Application USD Million (2025-2030)
  • Table 412. China Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 413. China Prebiotics, by Demography USD Million (2025-2030)
  • Table 414. China Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 415. Japan Prebiotics, by Type USD Million (2025-2030)
  • Table 416. Japan Prebiotics, by Application USD Million (2025-2030)
  • Table 417. Japan Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 418. Japan Prebiotics, by Demography USD Million (2025-2030)
  • Table 419. Japan Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 420. India Prebiotics, by Type USD Million (2025-2030)
  • Table 421. India Prebiotics, by Application USD Million (2025-2030)
  • Table 422. India Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 423. India Prebiotics, by Demography USD Million (2025-2030)
  • Table 424. India Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 425. South Korea Prebiotics, by Type USD Million (2025-2030)
  • Table 426. South Korea Prebiotics, by Application USD Million (2025-2030)
  • Table 427. South Korea Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 428. South Korea Prebiotics, by Demography USD Million (2025-2030)
  • Table 429. South Korea Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 430. Taiwan Prebiotics, by Type USD Million (2025-2030)
  • Table 431. Taiwan Prebiotics, by Application USD Million (2025-2030)
  • Table 432. Taiwan Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 433. Taiwan Prebiotics, by Demography USD Million (2025-2030)
  • Table 434. Taiwan Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 435. Australia Prebiotics, by Type USD Million (2025-2030)
  • Table 436. Australia Prebiotics, by Application USD Million (2025-2030)
  • Table 437. Australia Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 438. Australia Prebiotics, by Demography USD Million (2025-2030)
  • Table 439. Australia Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 440. Rest of Asia-Pacific Prebiotics, by Type USD Million (2025-2030)
  • Table 441. Rest of Asia-Pacific Prebiotics, by Application USD Million (2025-2030)
  • Table 442. Rest of Asia-Pacific Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 443. Rest of Asia-Pacific Prebiotics, by Demography USD Million (2025-2030)
  • Table 444. Rest of Asia-Pacific Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 445. Europe Prebiotics, by Country USD Million (2025-2030)
  • Table 446. Europe Prebiotics, by Type USD Million (2025-2030)
  • Table 447. Europe Prebiotics, by Application USD Million (2025-2030)
  • Table 448. Europe Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 449. Europe Prebiotics, by Demography USD Million (2025-2030)
  • Table 450. Europe Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 451. Germany Prebiotics, by Type USD Million (2025-2030)
  • Table 452. Germany Prebiotics, by Application USD Million (2025-2030)
  • Table 453. Germany Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 454. Germany Prebiotics, by Demography USD Million (2025-2030)
  • Table 455. Germany Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 456. France Prebiotics, by Type USD Million (2025-2030)
  • Table 457. France Prebiotics, by Application USD Million (2025-2030)
  • Table 458. France Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 459. France Prebiotics, by Demography USD Million (2025-2030)
  • Table 460. France Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 461. Italy Prebiotics, by Type USD Million (2025-2030)
  • Table 462. Italy Prebiotics, by Application USD Million (2025-2030)
  • Table 463. Italy Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 464. Italy Prebiotics, by Demography USD Million (2025-2030)
  • Table 465. Italy Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 466. United Kingdom Prebiotics, by Type USD Million (2025-2030)
  • Table 467. United Kingdom Prebiotics, by Application USD Million (2025-2030)
  • Table 468. United Kingdom Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 469. United Kingdom Prebiotics, by Demography USD Million (2025-2030)
  • Table 470. United Kingdom Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 471. Netherlands Prebiotics, by Type USD Million (2025-2030)
  • Table 472. Netherlands Prebiotics, by Application USD Million (2025-2030)
  • Table 473. Netherlands Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 474. Netherlands Prebiotics, by Demography USD Million (2025-2030)
  • Table 475. Netherlands Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 476. Rest of Europe Prebiotics, by Type USD Million (2025-2030)
  • Table 477. Rest of Europe Prebiotics, by Application USD Million (2025-2030)
  • Table 478. Rest of Europe Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 479. Rest of Europe Prebiotics, by Demography USD Million (2025-2030)
  • Table 480. Rest of Europe Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 481. MEA Prebiotics, by Country USD Million (2025-2030)
  • Table 482. MEA Prebiotics, by Type USD Million (2025-2030)
  • Table 483. MEA Prebiotics, by Application USD Million (2025-2030)
  • Table 484. MEA Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 485. MEA Prebiotics, by Demography USD Million (2025-2030)
  • Table 486. MEA Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 487. Middle East Prebiotics, by Type USD Million (2025-2030)
  • Table 488. Middle East Prebiotics, by Application USD Million (2025-2030)
  • Table 489. Middle East Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 490. Middle East Prebiotics, by Demography USD Million (2025-2030)
  • Table 491. Middle East Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 492. Africa Prebiotics, by Type USD Million (2025-2030)
  • Table 493. Africa Prebiotics, by Application USD Million (2025-2030)
  • Table 494. Africa Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 495. Africa Prebiotics, by Demography USD Million (2025-2030)
  • Table 496. Africa Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 497. North America Prebiotics, by Country USD Million (2025-2030)
  • Table 498. North America Prebiotics, by Type USD Million (2025-2030)
  • Table 499. North America Prebiotics, by Application USD Million (2025-2030)
  • Table 500. North America Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 501. North America Prebiotics, by Demography USD Million (2025-2030)
  • Table 502. North America Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 503. United States Prebiotics, by Type USD Million (2025-2030)
  • Table 504. United States Prebiotics, by Application USD Million (2025-2030)
  • Table 505. United States Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 506. United States Prebiotics, by Demography USD Million (2025-2030)
  • Table 507. United States Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 508. Canada Prebiotics, by Type USD Million (2025-2030)
  • Table 509. Canada Prebiotics, by Application USD Million (2025-2030)
  • Table 510. Canada Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 511. Canada Prebiotics, by Demography USD Million (2025-2030)
  • Table 512. Canada Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 513. Mexico Prebiotics, by Type USD Million (2025-2030)
  • Table 514. Mexico Prebiotics, by Application USD Million (2025-2030)
  • Table 515. Mexico Prebiotics, by Disease Type USD Million (2025-2030)
  • Table 516. Mexico Prebiotics, by Demography USD Million (2025-2030)
  • Table 517. Mexico Prebiotics, by Distribution Channel USD Million (2025-2030)
  • Table 518. Prebiotics Sales: by Type(Kilo Tons)
  • Table 519. Prebiotics Sales Fructo-Oligosaccharides , by Region Kilo Tons (2025-2030)
  • Table 520. Prebiotics Sales Insulin , by Region Kilo Tons (2025-2030)
  • Table 521. Prebiotics Sales Pyrodextrins , by Region Kilo Tons (2025-2030)
  • Table 522. Prebiotics Sales Galacto-Oligosaccharides , by Region Kilo Tons (2025-2030)
  • Table 523. Prebiotics Sales Soya Oligosaccharides , by Region Kilo Tons (2025-2030)
  • Table 524. Prebiotics Sales Lactulose , by Region Kilo Tons (2025-2030)
  • Table 525. Prebiotics Sales Isomalto-Oligosaccharides , by Region Kilo Tons (2025-2030)
  • Table 526. Prebiotics Sales Others , by Region Kilo Tons (2025-2030)
  • Table 527. Prebiotics Sales: by Application(Kilo Tons)
  • Table 528. Prebiotics Sales Functional Food & Beverages , by Region Kilo Tons (2025-2030)
  • Table 529. Prebiotics Sales Non-Dairy Beverages , by Region Kilo Tons (2025-2030)
  • Table 530. Prebiotics Sales Dietary Supplements , by Region Kilo Tons (2025-2030)
  • Table 531. Prebiotics Sales Cereals , by Region Kilo Tons (2025-2030)
  • Table 532. Prebiotics Sales Infant Formula , by Region Kilo Tons (2025-2030)
  • Table 533. Prebiotics Sales Animal Feed , by Region Kilo Tons (2025-2030)
  • Table 534. Prebiotics Sales: by Disease Type(Kilo Tons)
  • Table 535. Prebiotics Sales Diabetes , by Region Kilo Tons (2025-2030)
  • Table 536. Prebiotics Sales Infections , by Region Kilo Tons (2025-2030)
  • Table 537. Prebiotics Sales Cardiovascular Diseases , by Region Kilo Tons (2025-2030)
  • Table 538. Prebiotics Sales Osteoporosis , by Region Kilo Tons (2025-2030)
  • Table 539. Prebiotics Sales IBD , by Region Kilo Tons (2025-2030)
  • Table 540. Prebiotics Sales Immunomodulation , by Region Kilo Tons (2025-2030)
  • Table 541. Prebiotics Sales Others , by Region Kilo Tons (2025-2030)
  • Table 542. Prebiotics Sales: by Demography(Kilo Tons)
  • Table 543. Prebiotics Sales Pediatric , by Region Kilo Tons (2025-2030)
  • Table 544. Prebiotics Sales Adult , by Region Kilo Tons (2025-2030)
  • Table 545. Prebiotics Sales Geriatric , by Region Kilo Tons (2025-2030)
  • Table 546. Prebiotics Sales: by Distribution Channel(Kilo Tons)
  • Table 547. Prebiotics Sales Hypermarkets/Supermarkets , by Region Kilo Tons (2025-2030)
  • Table 548. Prebiotics Sales Pharmacies and Drug Stores , by Region Kilo Tons (2025-2030)
  • Table 549. Prebiotics Sales Specialty Stores , by Region Kilo Tons (2025-2030)
  • Table 550. Prebiotics Sales Online Sales , by Region Kilo Tons (2025-2030)
  • Table 551. South America Prebiotics Sales, by Country Kilo Tons (2025-2030)
  • Table 552. South America Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 553. South America Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 554. South America Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 555. South America Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 556. South America Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 557. Brazil Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 558. Brazil Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 559. Brazil Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 560. Brazil Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 561. Brazil Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 562. Argentina Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 563. Argentina Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 564. Argentina Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 565. Argentina Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 566. Argentina Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 567. Rest of South America Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 568. Rest of South America Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 569. Rest of South America Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 570. Rest of South America Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 571. Rest of South America Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 572. Asia Pacific Prebiotics Sales, by Country Kilo Tons (2025-2030)
  • Table 573. Asia Pacific Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 574. Asia Pacific Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 575. Asia Pacific Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 576. Asia Pacific Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 577. Asia Pacific Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 578. China Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 579. China Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 580. China Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 581. China Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 582. China Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 583. Japan Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 584. Japan Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 585. Japan Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 586. Japan Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 587. Japan Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 588. India Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 589. India Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 590. India Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 591. India Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 592. India Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 593. South Korea Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 594. South Korea Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 595. South Korea Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 596. South Korea Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 597. South Korea Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 598. Taiwan Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 599. Taiwan Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 600. Taiwan Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 601. Taiwan Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 602. Taiwan Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 603. Australia Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 604. Australia Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 605. Australia Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 606. Australia Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 607. Australia Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 608. Rest of Asia-Pacific Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 609. Rest of Asia-Pacific Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 610. Rest of Asia-Pacific Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 611. Rest of Asia-Pacific Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 612. Rest of Asia-Pacific Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 613. Europe Prebiotics Sales, by Country Kilo Tons (2025-2030)
  • Table 614. Europe Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 615. Europe Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 616. Europe Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 617. Europe Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 618. Europe Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 619. Germany Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 620. Germany Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 621. Germany Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 622. Germany Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 623. Germany Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 624. France Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 625. France Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 626. France Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 627. France Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 628. France Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 629. Italy Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 630. Italy Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 631. Italy Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 632. Italy Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 633. Italy Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 634. United Kingdom Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 635. United Kingdom Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 636. United Kingdom Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 637. United Kingdom Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 638. United Kingdom Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 639. Netherlands Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 640. Netherlands Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 641. Netherlands Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 642. Netherlands Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 643. Netherlands Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 644. Rest of Europe Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 645. Rest of Europe Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 646. Rest of Europe Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 647. Rest of Europe Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 648. Rest of Europe Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 649. MEA Prebiotics Sales, by Country Kilo Tons (2025-2030)
  • Table 650. MEA Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 651. MEA Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 652. MEA Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 653. MEA Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 654. MEA Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 655. Middle East Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 656. Middle East Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 657. Middle East Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 658. Middle East Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 659. Middle East Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 660. Africa Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 661. Africa Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 662. Africa Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 663. Africa Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 664. Africa Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 665. North America Prebiotics Sales, by Country Kilo Tons (2025-2030)
  • Table 666. North America Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 667. North America Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 668. North America Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 669. North America Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 670. North America Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 671. United States Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 672. United States Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 673. United States Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 674. United States Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 675. United States Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 676. Canada Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 677. Canada Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 678. Canada Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 679. Canada Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 680. Canada Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 681. Mexico Prebiotics Sales, by Type Kilo Tons (2025-2030)
  • Table 682. Mexico Prebiotics Sales, by Application Kilo Tons (2025-2030)
  • Table 683. Mexico Prebiotics Sales, by Disease Type Kilo Tons (2025-2030)
  • Table 684. Mexico Prebiotics Sales, by Demography Kilo Tons (2025-2030)
  • Table 685. Mexico Prebiotics Sales, by Distribution Channel Kilo Tons (2025-2030)
  • Table 686. Prebiotics: by Type(USD/Units)
  • Table 687. Research Programs/Design for This Report
  • Table 688. Key Data Information from Secondary Sources
  • Table 689. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Prebiotics: by Type USD Million (2018-2023)
  • Figure 5. Global Prebiotics: by Application USD Million (2018-2023)
  • Figure 6. Global Prebiotics: by Disease Type USD Million (2018-2023)
  • Figure 7. Global Prebiotics: by Demography USD Million (2018-2023)
  • Figure 8. Global Prebiotics: by Distribution Channel USD Million (2018-2023)
  • Figure 9. South America Prebiotics Share (%), by Country
  • Figure 10. Asia Pacific Prebiotics Share (%), by Country
  • Figure 11. Europe Prebiotics Share (%), by Country
  • Figure 12. MEA Prebiotics Share (%), by Country
  • Figure 13. North America Prebiotics Share (%), by Country
  • Figure 14. Global Prebiotics: by Type Kilo Tons (2018-2023)
  • Figure 15. Global Prebiotics: by Application Kilo Tons (2018-2023)
  • Figure 16. Global Prebiotics: by Disease Type Kilo Tons (2018-2023)
  • Figure 17. Global Prebiotics: by Demography Kilo Tons (2018-2023)
  • Figure 18. Global Prebiotics: by Distribution Channel Kilo Tons (2018-2023)
  • Figure 19. South America Prebiotics Share (%), by Country
  • Figure 20. Asia Pacific Prebiotics Share (%), by Country
  • Figure 21. Europe Prebiotics Share (%), by Country
  • Figure 22. MEA Prebiotics Share (%), by Country
  • Figure 23. North America Prebiotics Share (%), by Country
  • Figure 24. Global Prebiotics: by Type USD/Units (2018-2023)
  • Figure 25. Global Prebiotics share by Players 2023 (%)
  • Figure 26. Global Prebiotics share by Players (Top 3) 2023(%)
  • Figure 27. Global Prebiotics share by Players (Top 5) 2023(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Abbott Nutrition (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Nutrition (United States) Revenue: by Geography 2023
  • Figure 31. Cargill, Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 32. Cargill, Incorporated (United States) Revenue: by Geography 2023
  • Figure 33. Danone SA (France) Revenue, Net Income and Gross profit
  • Figure 34. Danone SA (France) Revenue: by Geography 2023
  • Figure 35. DuPont Nutrition & Health (Denmark) Revenue, Net Income and Gross profit
  • Figure 36. DuPont Nutrition & Health (Denmark) Revenue: by Geography 2023
  • Figure 37. Nestl S.A. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. Nestl S.A. (Switzerland) Revenue: by Geography 2023
  • Figure 39. Yakult Pharmaceutical Industry Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 40. Yakult Pharmaceutical Industry Co., Ltd. (Japan) Revenue: by Geography 2023
  • Figure 41. Fonterra Co-operative Group Limited (New Zealand) Revenue, Net Income and Gross profit
  • Figure 42. Fonterra Co-operative Group Limited (New Zealand) Revenue: by Geography 2023
  • Figure 43. Ingredion Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 44. Ingredion Incorporated (United States) Revenue: by Geography 2023
  • Figure 45. CPIngredients, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 46. CPIngredients, LLC (United States) Revenue: by Geography 2023
  • Figure 47. Jarrow Formulas, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Jarrow Formulas, Inc. (United States) Revenue: by Geography 2023
  • Figure 49. Kerry Group plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 50. Kerry Group plc (Ireland) Revenue: by Geography 2023
  • Figure 51. Kirkman Group, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 52. Kirkman Group, Inc. (United States) Revenue: by Geography 2023
  • Figure 53. Global Prebiotics: by Type USD Million (2025-2030)
  • Figure 54. Global Prebiotics: by Application USD Million (2025-2030)
  • Figure 55. Global Prebiotics: by Disease Type USD Million (2025-2030)
  • Figure 56. Global Prebiotics: by Demography USD Million (2025-2030)
  • Figure 57. Global Prebiotics: by Distribution Channel USD Million (2025-2030)
  • Figure 58. South America Prebiotics Share (%), by Country
  • Figure 59. Asia Pacific Prebiotics Share (%), by Country
  • Figure 60. Europe Prebiotics Share (%), by Country
  • Figure 61. MEA Prebiotics Share (%), by Country
  • Figure 62. North America Prebiotics Share (%), by Country
  • Figure 63. Global Prebiotics: by Type Kilo Tons (2025-2030)
  • Figure 64. Global Prebiotics: by Application Kilo Tons (2025-2030)
  • Figure 65. Global Prebiotics: by Disease Type Kilo Tons (2025-2030)
  • Figure 66. Global Prebiotics: by Demography Kilo Tons (2025-2030)
  • Figure 67. Global Prebiotics: by Distribution Channel Kilo Tons (2025-2030)
  • Figure 68. South America Prebiotics Share (%), by Country
  • Figure 69. Asia Pacific Prebiotics Share (%), by Country
  • Figure 70. Europe Prebiotics Share (%), by Country
  • Figure 71. MEA Prebiotics Share (%), by Country
  • Figure 72. North America Prebiotics Share (%), by Country
  • Figure 73. Global Prebiotics: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Abbott Nutrition (United States)
  • Cargill, Incorporated (United States)
  • Danone SA (France)
  • DuPont Nutrition & Health (Denmark)
  • Nestl S.A. (Switzerland)
  • Yakult Pharmaceutical Industry Co., Ltd. (Japan)
  • Fonterra Co-operative Group Limited (New Zealand)
  • Ingredion Incorporated (United States)
  • CPIngredients, LLC (United States)
  • Jarrow Formulas, Inc. (United States)
  • Kerry Group plc (Ireland)
  • Kirkman Group, Inc. (United States)
Additional players considered in the study are as follows:
Beghin Meiji S.A. (France) , BENEO-Orafti SA (Belgium) , FrieslandCampina Domo (United States) , Weetabix Limited (United Kingdom) , FrieslandCampina Domo (United States) , Weetabix Limited (United Kingdom) , Nexira SAS (France) , Roquette America, Inc. (United States) , Royal FrieslandCampina N.V. (The Netherlands)
Select User Access Type

Key Highlights of Report


May 2024 159 Pages 56 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Prebiotics Quantitative research analysis
Global Prebiotics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Nutrition (United States), Cargill, Incorporated (United States), Danone SA (France), DuPont Nutrition & Health (Denmark), Nestl S.A. (Switzerland), Yakult Pharmaceutical Industry Co., Ltd. (Japan), Fonterra Co-operative Group Limited (New Zealand), Ingredion Incorporated (United States), CPIngredients, LLC (United States), Jarrow Formulas, Inc. (United States), Kerry Group plc (Ireland) and Kirkman Group, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Importance of the Animal Feed Ingredients " is seen as one of major influencing trends for Prebiotics Market during projected period 2023-2030.
The Prebiotics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Prebiotics Report?

Have a Query? Click Here

Other Related Reports

Extruded Snacks Comprehensive Study by Type (Extruded Filled Pillow Puffs, Extruded Crispy Chips, Extruded Snacks Sticks, Others), Raw Material (Potato, Rice, Corn, Mixed Grains, Other), Sales Channe...
$ 3650
Flavored Salts Comprehensive Study by Type (Sea Salt, Mined Salt), Flavour (Garlic Salt, Onion Salt, Smoked Salt, Celery Salt, Truffle Salt, Other), Distribution Channel (Online Stores, Offline Reta...
$ 3450
Whole Milk Powder Comprehensive Study by Type (Regular Whole Milk Formula, Instant Whole Milk Formula, Others), Application (Dairy, Snacks, Bakery & Confectionery, Ice Cream & Desserts, Others (Suppl...
$ 3750
Vegetable Chutney Comprehensive Study by Type (Adamant Creeper Chutney, Coriander Leaves Chutney, Emblica Chutney, Others), Application (Household, Restaurants, Others), Nature (Gluten-free, Spicy or...
$ 3800
Pistachio Comprehensive Study by Form (Whole, Powdered, Roasted, Splits), Industry Verticals (Bakery and Confectionery, Flavoured Drink, Breakfast Cereals, Snacks, Butter and Spread, Dairy Products, ...
$ 3650
Cooking Fat Comprehensive Study by Type (Vegetable Fat, Animal Fat, Mixed Fat), Application (Bakery, Confectionery, Frying, Others), Fatty Acid (Saturated, Monounsaturated, Polyunsaturated), Distribu...
$ 3450